Dang CT - Search Results

1

Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer.

Krop IE, Suter TM, Dang CT, Dirix L, Romieu G, Zamagni C, Citron ML, Campone M, Xu N, Smitt M, Gianni L. Krop IE, et al. Among authors: dang ct. J Clin Oncol. 2015 Apr 1;33(10):1136-42. doi: 10.1200/JCO.2014.58.7782. Epub 2015 Feb 23. J Clin Oncol. 2015. PMID: 25713436 Free PMC article. Clinical Trial.

2

Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.

Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, Seidman AD, D'Andrea GM, Theodoulou M, Panageas KS, Norton L, Hudis CA. Dang CT, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4062-7. doi: 10.1158/1078-0432.CCR-03-0463. Clin Cancer Res. 2004. PMID: 15217939 Clinical Trial.

3

Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.

Dang CT, D'Andrea GM, Moynahan ME, Dickler MN, Seidman AD, Fornier M, Robson ME, Theodoulou M, Lake D, Currie VE, Hurria A, Panageas KS, Norton L, Hudis CA. Dang CT, et al. Clin Cancer Res. 2004 Sep 1;10(17):5754-61. doi: 10.1158/1078-0432.CCR-04-0634. Clin Cancer Res. 2004. PMID: 15355903 Clinical Trial.

4

Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.

Dang CT. Dang CT. Expert Rev Anticancer Ther. 2006 Mar;6(3):427-36. doi: 10.1586/14737140.6.3.427. Expert Rev Anticancer Ther. 2006. PMID: 16503859 Review.

5

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.

Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C. Hurria A, et al. Breast Cancer Res Treat. 2006 Aug;98(3):343-8. doi: 10.1007/s10549-006-9171-6. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541322

6

Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.

Dang C, Hudis C. Dang C, et al. Clin Breast Cancer. 2006 Apr;7(1):51-8. doi: 10.3816/CBC.2006.n.013. Clin Breast Cancer. 2006. PMID: 16764744 Review.

7

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J. Hurria A, et al. J Am Geriatr Soc. 2006 Jun;54(6):925-31. doi: 10.1111/j.1532-5415.2006.00732.x. J Am Geriatr Soc. 2006. PMID: 16776787

8

A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Hurria A, Zuckerman E, Panageas KS, Fornier M, D'Andrea G, Dang C, Moasser M, Robson M, Seidman A, Currie V, VanPoznak C, Theodoulou M, Lachs MS, Hudis C. Hurria A, et al. J Am Geriatr Soc. 2006 Jul;54(7):1119-24. doi: 10.1111/j.1532-5415.2006.00789.x. J Am Geriatr Soc. 2006. PMID: 16866685

9

Cardiac dysfunction associated with trastuzumab.

Smith KL, Dang C, Seidman AD. Smith KL, et al. Expert Opin Drug Saf. 2006 Sep;5(5):619-29. doi: 10.1517/14740338.5.5.619. Expert Opin Drug Saf. 2006. PMID: 16907652 Review.

10

Current status of the taxanes as adjuvant therapy for breast cancer.

Hudis C, McArthur H, Dang C. Hudis C, et al. Breast. 2007 Dec;16 Suppl 2:S132-5. doi: 10.1016/j.breast.2007.07.022. Epub 2007 Aug 27. Breast. 2007. PMID: 17723302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page